Celemics, Inc. (331920.KQ)
KOSDAQ · KRW · Healthcare · Medical Devices
₩8,690 (+0.93%) as of
Key statistics
- Market cap
- 97.17B
- Dividend yield
- 0.00%
- 52-week range
- 2,535.00 – 19,840.00
- Beta
- -0.05
- Revenue (TTM)
- 5.22B
- Profit margin
- -194.78%
- Volume
- 38.77k
About Celemics, Inc.
Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development services. Its products are used in oncology, liquid biopsy, biopharma solutions, inherited diseases, pharmacogenomics, virus research, agrigenomics, RNA sequencing, epigenetics, metagenomic sequencing, antibody discovery, and bioinformatics applications. The company was founded in 2010 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Seoul, South Korea
- Employees
- 46
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.